Home › Funds › ORBIMED ADVISORS LLC › CELC
ORBIMED ADVISORS LLC position in CELC
CELCUITY INC · Health Care
ORBIMED ADVISORS LLC reported holding 314,500 shares of CELC (CELCUITY INC) in its Q3 2026 13F filing — a position valued at US$25.0M, representing 0.51% of its reported portfolio and ranking #44 among its reported holdings. ORBIMED ADVISORS LLC has disclosed CELC holdings in 3 of the last 5 reported quarters, going back to Q3 2025.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How ORBIMED ADVISORS LLC's CELC position evolved
ORBIMED ADVISORS LLC first disclosed a stake in CELC in Q3 2025 at 2,000,000 shares (US$2.7M). The position peaked in Q3 2026 at 314,500 shares, worth US$25.0M. Across 3 filings, ORBIMED ADVISORS LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 314,500 shares valued at US$25.0M. Notable position changes include a 96% trim in Q4 2025 (shares rose 14% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 2.00M | $2.68M | New |
| Q4 2025 | 85.66K | $8.54M | Reduce |
| Q3 2026 | 314.50K | $25.01M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CELC and 13F data
CELC (CELCUITY INC) is a Health Care company. 52 other funds we track also report a position in CELC — the largest reported positions include RTW INVESTMENTS, LP (US$262.8M), Point72 Asset Management (US$140.3M), NEA Management Company, LLC (US$136.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CELC
- RTW INVESTMENTS, LP 3.30M sh · $262.81M · Q3 2026
- Point72 Asset Management 1.76M sh · $140.35M · Q3 2026
- NEA Management Company, LLC 1.71M sh · $136.02M · Q3 2026
- Soleus Capital Management, L.P. 1.68M sh · $133.81M · Q3 2026
- Avoro Capital Advisors LLC 1.50M sh · $119.28M · Q3 2026
- TANG CAPITAL MANAGEMENT LLC 1.46M sh · $116.46M · Q3 2026
- Hood River Capital Management LLC 1.29M sh · $102.66M · Q3 2026
- TORONTO DOMINION BANK 1.26M sh · $100.10M · Q3 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 100.00M sh · $96.48M · Q3 2026
- SILVERARC CAPITAL MANAGEMENT, LLC 803.19K sh · $63.87M · Q3 2026
- BAKER BROS. ADVISORS LP 30.75M sh · $55.46M · Q3 2026
- APIS CAPITAL ADVISORS, LLC 567.20K sh · $45.10M · Q3 2026
More on ORBIMED ADVISORS LLC
FAQ
How long has ORBIMED ADVISORS LLC held CELC?
ORBIMED ADVISORS LLC has disclosed CELC holdings in 3 of the last 5 reported quarters, going back to Q3 2025.
What is ORBIMED ADVISORS LLC's current position in CELC?
As of Q3 2026, ORBIMED ADVISORS LLC holds 314.50K shares of CELC (CELCUITY INC), valued at $25.01M, representing 0.51% of its reported portfolio and ranking #44.
Has ORBIMED ADVISORS LLC been buying or selling CELC?
In the latest 13F filing (Q3 2026), ORBIMED ADVISORS LLC newly opened its position in CELC. The position peaked in Q3 2026 at 314.50K shares.
Which other funds hold CELC?
Other major institutional holders of CELC include RTW INVESTMENTS, LP, Point72 Asset Management, NEA Management Company, LLC, among 52 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.